.jpg)
Hims & Hers Health, Inc. (HIMS)
28.01
0.00 (0.00%)
Upcoming Events
Latest Headlines
Hims & Hers appoints Dr. Anant Vinjamoori as chief medical officer
June 4, 2026 9:00 AM - StreetInsider
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
June 4, 2026 9:00 AM - BizWire
Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
June 3, 2026 7:05 AM - StreetInsider
Leerink Reiterates Market Perform Rating on Hims and Hers (HIMS)
June 2, 2026 8:19 AM - StreetInsider
Form 8-K Hims & Hers Health, Inc. For: May 29
June 2, 2026 6:09 AM - SEC Filing
Hims & Hers completes acquisition of Eucalyptus
June 2, 2026 5:00 AM - StreetInsider
HIMS & HERS completes Eucalyptus acquisition to expand in Canada
June 2, 2026 5:00 AM - StreetInsider
Hims & Hers completes Eucalyptus acquisition to expand in Germany
June 2, 2026 5:00 AM - StreetInsider
Hims & Hers completes Eucalyptus acquisition, enters Australia market
June 2, 2026 5:00 AM - StreetInsider
HIMS & Hers completes acquisition of Eucalyptus to enter Japan market
June 2, 2026 5:00 AM - StreetInsider
Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform
June 2, 2026 5:00 AM - BizWire
Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians
June 2, 2026 5:00 AM - BizWire
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
June 2, 2026 5:00 AM - BizWire
Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany
June 2, 2026 5:00 AM - BizWire
Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market
June 2, 2026 5:00 AM - BizWire
HIMS adds eight wellness partners to subscriber benefits program
May 28, 2026 12:02 PM - StreetInsider
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
May 28, 2026 12:00 PM - BizWire
Hims & Hers Health, Inc. (HIMS) Spikes 2.8% as Board of Directors David Wells Buys $1.1mn Worth of Stock
May 26, 2026 5:14 PM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: May 26 Filed by: WELLS DAVID B
May 26, 2026 4:48 PM - SEC Filing
Hims and Hers (HIMS) PT Lowered to $25 at BofA Securities
May 26, 2026 5:25 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: May 20 Filed by: Carroll Patrick Harrison
May 22, 2026 4:17 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: May 20 Filed by: WELLS DAVID B
May 22, 2026 4:17 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: May 20 Filed by: Payne Christopher D
May 22, 2026 4:17 PM - SEC Filing
Hims and Hers (HIMS) PT Raised to $23 at Truist Securities
May 22, 2026 5:42 AM - StreetInsider
Form 8-K Hims & Hers Health, Inc. For: May 21
May 21, 2026 5:06 PM - SEC Filing
Hims & Hers launches generic semaglutide in Canada at $149 monthly
May 21, 2026 9:01 AM - StreetInsider
Hims & Hers launches generic semaglutide in Canada at $149 monthly
May 21, 2026 9:00 AM - StreetInsider
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
May 21, 2026 9:00 AM - BizWire
Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
May 21, 2026 9:00 AM - BizWire
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
May 21, 2026 9:00 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: May 18 Filed by: Okupe Oluyemi
May 19, 2026 7:39 PM - SEC Filing
Form 8-K Hims & Hers Health, Inc. For: May 18
May 19, 2026 8:18 AM - SEC Filing
HIMS prices $350 million convertible notes offering for expansion plans
May 18, 2026 11:59 PM - StreetInsider
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
May 18, 2026 11:59 PM - BizWire
Hims and Hers (HIMS) PT Lowered to $28 at BofA Securities
May 18, 2026 9:04 AM - StreetInsider
Hims & Hers announces $300 million convertible notes offering
May 18, 2026 7:16 AM - StreetInsider
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
May 18, 2026 7:16 AM - BizWire
Form SCHEDULE 13G Hims & Hers Health, Inc. Filed by: SUSQUEHANNA SECURITIES, LLC
May 15, 2026 12:31 PM - SEC Filing
Form SCHEDULE 13G/A Hims & Hers Health, Inc. Filed by: Capital World Investors
May 14, 2026 1:56 PM - SEC Filing
Hims and Hers (HIMS) PT Lowered to $24.50 at Jefferies, 'execution story now'
May 12, 2026 10:41 AM - StreetInsider
Hims and Hers (HIMS) PT Lowered to $30 at BofA Securities
May 12, 2026 9:10 AM - StreetInsider
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
May 12, 2026 9:00 AM - StreetInsider
Hims and Hers (HIMS) PT Lowered to $33 at JPMorgan
May 12, 2026 8:08 AM - StreetInsider
Hims & Hers stock tumbles as revenue, EBITDA miss estimates
May 12, 2026 7:56 AM - StreetInsider
BTIG on Hims and Hers (HIMS): 'will need to aggressively manage sales and marketing costs'
May 12, 2026 7:51 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $25 at TD Cowen
May 12, 2026 7:27 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $35 at Needham
May 12, 2026 7:12 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $35 at Needham
May 12, 2026 6:20 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $28 at Citi
May 12, 2026 5:22 AM - StreetInsider
Evercore ISI on Hims and Hers (HIMS): 'Prognosis Unclear'
May 12, 2026 5:19 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $32 at Canaccord
May 12, 2026 5:11 AM - StreetInsider
Hims & Hers reports surprise loss in Q1, shares dive after hours
May 11, 2026 4:38 PM - StreetInsider
Form 10-Q Hims & Hers Health, Inc. For: Mar 31
May 11, 2026 4:17 PM - SEC Filing
Form 8-K Hims & Hers Health, Inc. For: May 11
May 11, 2026 4:09 PM - SEC Filing
Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 41c, Misses on Revenue; Offers FY26 Revenue Guidance
May 11, 2026 4:06 PM - StreetInsider
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
May 11, 2026 4:05 PM - BizWire
Hims & Hers earnings preview: BofA says company lost GLP-1 share in 1Q
May 11, 2026 12:00 PM - StreetInsider
Hims & Hers Health, Inc. (HIMS) call put ratio 3.4 calls to 1 put with a focus on 1K contracts of January 105 calls into quarter results
May 11, 2026 10:49 AM - StreetInsider
Truist on Hims and Hers (HIMS): 'NVO Partnership Off to a Solid Start'
May 11, 2026 9:39 AM - StreetInsider
Hims & Hers Health, Inc. (HIMS) spreader of May calls into quarter results
May 8, 2026 10:54 AM - StreetInsider
Hims & Hers Health, Inc. (HIMS) spreader of 2K contracts of May 28 and 30 calls into quarter results
May 8, 2026 4:54 AM - StreetInsider
Amazon Pharmacy adds same-day delivery for Ozempic pill
May 7, 2026 7:04 AM - StreetInsider
Form ARS Hims & Hers Health, Inc. For: Dec 31
April 28, 2026 8:41 AM - SEC Filing
Hims & Hers nominates Kofi Amoo-Gottfried to board of directors
April 28, 2026 8:35 AM - StreetInsider
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
April 28, 2026 8:35 AM - BizWire
Form DEFA14A Hims & Hers Health, Inc.
April 28, 2026 8:26 AM - SEC Filing
Form DEF 14A Hims & Hers Health, Inc. For: Jun 11
April 28, 2026 8:24 AM - SEC Filing
JPMorgan Starts Hims and Hers (HIMS) at Overweight
April 24, 2026 2:15 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $32 at BofA Securities
April 23, 2026 9:49 AM - StreetInsider
Hims & Hers expands platform to include Eli Lilly weight loss medications
April 23, 2026 8:40 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: Apr 20 Filed by: Boughton Soleil
April 22, 2026 5:24 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Apr 20 Filed by: Okupe Oluyemi
April 22, 2026 5:24 PM - SEC Filing
Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
April 21, 2026 1:33 PM - StreetInsider
Amazon One Medical launches weight management program with GLP-1 drugs
April 21, 2026 9:10 AM - StreetInsider
Hims & Hers Extends Drop To 6% After Amazon Glp-1 News
April 21, 2026 9:09 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: Apr 16 Filed by: Okupe Oluyemi
April 20, 2026 4:38 PM - SEC Filing
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
April 20, 2026 1:19 PM - SEC Filing
FDA encourages testosterone therapy makers to seek low libido indication
April 16, 2026 11:31 AM - StreetInsider
Leerink Partners on Hims and Hers (HIMS): FDA meeting to discuss peptide restrictions 'clear positive,' could fill growth hole
April 16, 2026 11:11 AM - StreetInsider
Hims and Hers (HIMS) PT Raised to $25 at BofA Securities
April 15, 2026 5:06 PM - StreetInsider
Hims & Hers Health, Inc. (HIMS) Strength Tied to RFK Jr Comments on Peptides
April 15, 2026 2:16 PM - StreetInsider
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
April 13, 2026 4:05 PM - BizWire
Form 4 Hims & Hers Health, Inc. For: Apr 09 Filed by: Dudum Andrew
April 10, 2026 6:57 PM - SEC Filing
Hims and Hers (HIMS) PT Lowered to $21 at BofA Securities
April 8, 2026 5:11 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: Apr 06 Filed by: Okupe Oluyemi
April 7, 2026 5:15 PM - SEC Filing
Form 144 Hims & Hers Health, Inc. Filed by: Okupe Oluyemi
April 6, 2026 6:04 PM - SEC Filing
Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
March 31, 2026 6:35 AM - StreetInsider
Form SCHEDULE 13G/A Hims & Hers Health, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 9:33 AM - SEC Filing
Hims and Hers (HIMS) PT Lowered to $23 at TD Cowen
March 27, 2026 9:20 AM - StreetInsider
Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'
March 27, 2026 5:12 AM - StreetInsider
BofA on Hims and Hers (HIMS): '$149/month subscription fee is slightly higher than we initially expected'
March 26, 2026 1:17 PM - StreetInsider
HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications
March 26, 2026 12:00 PM - StreetInsider
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
March 26, 2026 12:00 PM - BizWire
Form 4 Hims & Hers Health, Inc. For: Mar 20 Filed by: Okupe Oluyemi
March 24, 2026 6:10 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 17 Filed by: Becklund Irene
March 18, 2026 4:18 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 17 Filed by: Chi Michael
March 18, 2026 4:18 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 17 Filed by: Boughton Soleil
March 18, 2026 4:18 PM - SEC Filing
HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk
March 18, 2026 8:54 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Chi Michael
March 17, 2026 4:30 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Pendarvis Christiane
March 17, 2026 4:30 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Carroll Patrick Harrison
March 17, 2026 4:30 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Autor Deborah M.
March 17, 2026 4:29 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Boughton Soleil
March 17, 2026 4:29 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Dudum Andrew
March 17, 2026 4:29 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Becklund Irene
March 17, 2026 4:29 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 13 Filed by: Okupe Oluyemi
March 17, 2026 4:29 PM - SEC Filing
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
March 17, 2026 12:42 PM - SEC Filing
Form 144 Hims & Hers Health, Inc. Filed by: Becklund Irene
March 17, 2026 11:39 AM - SEC Filing
Form 144 Hims & Hers Health, Inc. Filed by: Chi Michael
March 17, 2026 10:07 AM - SEC Filing
Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm
March 17, 2026 9:00 AM - Globe NewsWire
Street Calls of the Week
March 16, 2026 6:16 AM - StreetInsider
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Becklund Irene
March 13, 2026 4:21 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Autor Deborah M.
March 13, 2026 4:21 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Chi Michael
March 13, 2026 4:21 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Carroll Patrick Harrison
March 13, 2026 4:21 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Boughton Soleil
March 13, 2026 4:21 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Elshenawy Mohamed
March 13, 2026 4:20 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Dudum Andrew
March 13, 2026 4:20 PM - SEC Filing
Form 4 Hims & Hers Health, Inc. For: Mar 11 Filed by: Okupe Oluyemi
March 13, 2026 4:20 PM - SEC Filing
Hims shares set for best week on record after new Novo Nordisk deal
March 13, 2026 10:09 AM - StreetInsider
Form 8-K Hims & Hers Health, Inc. For: Mar 09
March 11, 2026 5:21 PM - SEC Filing
Hims and Hers (HIMS) PT Raised to $29 at Barclays
March 11, 2026 3:39 AM - StreetInsider
Hims & Hers hires ex-Eli Lilly PR chief Beiser as top communications officer
March 10, 2026 8:10 PM - StreetInsider
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
March 10, 2026 8:08 PM - BizWire
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
March 10, 2026 9:00 AM - BizWire
Hims and Hers (HIMS) PT Raised to $28 at Deutsche Bank
March 10, 2026 7:28 AM - StreetInsider
BofA Securities Upgrades Hims and Hers (HIMS) to Neutral
March 10, 2026 6:09 AM - StreetInsider
Canaccord Reiterates Buy Rating on Hims and Hers (HIMS)
March 10, 2026 5:10 AM - StreetInsider
Citi Upgrades Hims and Hers (HIMS) to Neutral
March 9, 2026 4:10 PM - StreetInsider
Hims & Hers Health, Inc. (HIMS) call put ratio 2.2 calls to 1 put as share price up 41%
March 9, 2026 2:53 PM - StreetInsider
TD Cowen: 'Wegovy Injection may be declining'
March 9, 2026 12:23 PM - StreetInsider
Needham Upgrades Hims and Hers (HIMS) to Buy
March 9, 2026 11:24 AM - StreetInsider
Nephron Upgrades Hims and Hers (HIMS) to Buy
March 9, 2026 11:08 AM - StreetInsider
BTIG Reiterates Neutral Rating on Hims and Hers (HIMS) following Novo partnership
March 9, 2026 10:15 AM - StreetInsider
Truist Reiterates Hold Rating on Hims and Hers (HIMS)
March 9, 2026 8:58 AM - StreetInsider
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS) amid Novo partnership
March 9, 2026 8:46 AM - StreetInsider
HIMS partners with Novo Nordisk, shifts US weight loss strategy
March 9, 2026 8:30 AM - StreetInsider
Hims & Hers Announces Strategic Shift for US Weight Loss Business
March 9, 2026 8:30 AM - BizWire
Hims soars 44% on report Novo Nordisk to sell weight-loss drugs on its platform
March 9, 2026 6:53 AM - StreetInsider
Hims shares jump on deal to offer Novo's Wegovy, Ozempic on its platform
March 9, 2026 6:33 AM - StreetInsider
Full Article List
